Cited by 195Sphingolipid Metabolism and SignalingCardiac Ischemia and ReperfusionCell death mechanisms and regulation

Oxidative Stress–Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A–Associated Cardiac Cell Apoptosis

Open access
Pchejetski, Dimitri, Kunduzova, Oxana, Dayon, Audrey, Calise, Denis, Seguelas, Marie-Hélène, Leducq, Nathalie, Seif, Isabelle, Parini, Angelo +1 more·2007·Circulation Research

Abstract

The mitochondrial enzyme monoamine oxidase (MAO), its isoform MAO-A, plays a major role in reactive oxygen species–dependent cardiomyocyte apoptosis and postischemic cardiac damage. In the current study, we investigated whether sphingolipid metabolism can account for mediating MAO-A– and reactive oxygen species–dependent cardiomyocyte apoptosis. In H9c2 cardiomyoblasts, MAO-A–dependent reactive oxygen species generation led to mitochondria-mediated apoptosis, along with sphingosine kinase-1 (SphK1) inhibition. These phenomena were associated with generation of proapoptotic ceramide and decrease in prosurvival sphingosine 1-phosphate. These events were mimicked by inhibition of SphK1 with either pharmacological inhibitor or small interfering RNA, as well as by extracellular addition of C 2 -ceramide or H 2 O 2 . In contrast, enforced expression of SphK1 protected H9c2 cells from serotonin- or H 2 O 2 -induced apoptosis. Analysis of cardiac tissues from wild-type mice subjected to ischemia/reperfusion revealed significant upregulation of ceramide and inhibition of SphK1. It is noteworthy that SphK1 inhibition, ceramide accumulation, and concomitantly infarct size and cardiomyocyte apoptosis were significantly decreased in MAO-A–deficient animals. In conclusion, we show for the first time that the upregulation of ceramide/sphingosine 1-phosphate ratio is a critical event in MAO-A–mediated cardiac cell apoptosis. In addition, we provide the first evidence linking generation of reactive oxygen species with SphK1 inhibition. Finally, we propose sphingolipid metabolites as key mediators of postischemic/reperfusion cardiac injury.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.res.0000253900.66640.34

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased concentrations of ceramide may mediate apoptosis in the heart in response to ischemia or drugs or cytokines that promote apoptosis.

    “Although there is much evidence that increased concentrations of ceramide may mediate apoptosis in the heart in response to ischemia or drugs or cytokines that promote apoptosis, will promote cytochrome c release and apoptosis when directly applied to cardiomyocytes, and that inhibition of de novo ceramide synthesis prevents palmitate-induced apoptosis in L6 myotubes (75, 82, 276, 355, 368), it”

    From Cardiac remodeling in obesity (2008) · cites this paper as [276]

  • Ceramide promotes cytochrome c release and apoptosis when directly applied to cardiomyocytes.

    “Although there is much evidence that increased concentrations of ceramide may mediate apoptosis in the heart in response to ischemia or drugs or cytokines that promote apoptosis, will promote cytochrome c release and apoptosis when directly applied to cardiomyocytes, and that inhibition of de novo ceramide synthesis prevents palmitate-induced apoptosis in L6 myotubes (75, 82, 276, 355, 368), it”

    From Cardiac remodeling in obesity (2008) · cites this paper as [276]

  • Inhibition of de novo ceramide synthesis prevents palmitate-induced apoptosis in L6 myotubes.

    “Although there is much evidence that increased concentrations of ceramide may mediate apoptosis in the heart in response to ischemia or drugs or cytokines that promote apoptosis, will promote cytochrome c release and apoptosis when directly applied to cardiomyocytes, and that inhibition of de novo ceramide synthesis prevents palmitate-induced apoptosis in L6 myotubes (75, 82, 276, 355, 368), it”

    From Cardiac remodeling in obesity (2008) · cites this paper as [276]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 34 · Cited by 195

Authors
Pchejetski, D., Kunduzova, O., Dayon, A., Calise, D., Seguelas, M.-H., Leducq, N., Seif, I., Parini, A., & Cuvillier, O.
Affiliations
  • From Inserm U466 (D.P., A.D., O.C.), Toulouse; Inserm U388 (O.K., M.-H.S., A.P.), Toulouse; IFR 31 (D.C.), Service de Microchirurgie, Toulouse; Université Toulouse III Paul Sabatier (D.P., O.K., A.D., D.C., M.-H.S., A.P., O.C.); Cardiovascular and Thrombosis Department (N.L.), Sanofi-Aventis, Toulouse; and Université Paris-Sud (I.S.), Faculté de Pharmacie, Chatenay-Malabry, France. Current address for D.P., A.D., and O.C.: CNRS, Institut de Pharmacologie et de Biologie Structurale, UMR5089,...
  • Université Toulouse III - Paul Sabatier (FR)
Venue
Circulation Research
Published
2007-01-05
Volume
100
Issue
1
Pages
41-49
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2123227507
Cited by
195
References
34
Citations by year
2026: 2 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 16 · 2020: 18 · 2019: 12 · 2018: 12 · 2017: 13 · 2016: 9 · 2015: 8 · 2014: 13 · 2013: 11 · 2012: 9
FWCI
5.17
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
monoamine oxidase A, sphingosine kinase 1, cardiomyocyte apoptosis, reactive oxygen species, ceramide, sphingosine-1-phosphate, sphingolipid metabolism, oxidative stress, ischemia-reperfusion injury, mitochondrial apoptosis, H9c2 cells, serotonin, hydrogen peroxide
MeSH terms
Sphingosine Kinase, Animals, Cells, Cultured, Ceramides, Drug Resistance, Hydrogen Peroxide, Lysophospholipids, Mitochondria, Heart, Monoamine Oxidase, Serotonin, Sphingolipids, Sphingosine, Myocardial Reperfusion Injury, Down-Regulation, Up-Regulation, Oxidants, Rats, Sprague-Dawley, Apoptosis, Reactive Oxygen Species, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Oxidative Stress, Myocytes, Cardiac, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review